Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017
- PMID: 29346614
- PMCID: PMC5894077
- DOI: 10.1093/infdis/jiy027
Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017
Abstract
Background: Influenza A(H3N2) viruses circulated for 12 consecutive months in Hong Kong in 2016-2017, peaking in late June and July 2017. The objective of our study was to estimate the effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong.
Methods: We conducted a test-negative study between 1 September 2016 and 31 August 2017, enrolling children 6 months to 17 years of age hospitalized for an acute respiratory infection. Influenza was diagnosed by PCR on nasopharyngeal aspirates.
Results: We enrolled 5514 children, including 3608 children 6 months to 2 years, 1600 children 3-5 years, and 1206 children 6-17 years of age. Influenza-associated hospitalizations occurred throughout the study year but time of vaccination of these children was also wide spread, from September 2016 to May 2017. Influenza vaccine effectiveness (VE) was 39.7% (95% confidence interval [CI], 14.7%-57.3%) against laboratory-confirmed influenza A(H3N2). In analyses stratified by time since vaccination, the VE against influenza A(H3N2) was 52.8% (95% CI, 17.1%-73.2%) within 3 months of vaccination, and 31.2% (95% CI, -6.6% to 55.6%) 4-6 months after vaccination.
Conclusions: Influenza vaccination was effective in preventing hospitalizations in children in Hong Kong.
Figures
Similar articles
-
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023.Vaccine. 2024 Mar 19;42(8):1878-1882. doi: 10.1016/j.vaccine.2024.02.056. Epub 2024 Feb 22. Vaccine. 2024. PMID: 38395722
-
Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.Vaccine. 2021 Aug 9;39(34):4842-4848. doi: 10.1016/j.vaccine.2021.07.014. Epub 2021 Jul 21. Vaccine. 2021. PMID: 34301433
-
Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.Vaccine. 2016 Apr 27;34(19):2164-9. doi: 10.1016/j.vaccine.2016.03.032. Epub 2016 Mar 21. Vaccine. 2016. PMID: 27013437
-
The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.Vaccine. 2018 Oct 1;36(41):6117-6123. doi: 10.1016/j.vaccine.2018.08.075. Epub 2018 Sep 3. Vaccine. 2018. PMID: 30190121
-
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.Lancet Infect Dis. 2016 Aug;16(8):942-51. doi: 10.1016/S1473-3099(16)00129-8. Epub 2016 Apr 6. Lancet Infect Dis. 2016. PMID: 27061888 Review.
Cited by
-
Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.Lancet Respir Med. 2018 Dec;6(12):925-934. doi: 10.1016/S2213-2600(18)30419-3. Epub 2018 Nov 12. Lancet Respir Med. 2018. PMID: 30442587 Free PMC article.
-
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections.Emerg Microbes Infect. 2022 Dec;11(1):1742-1750. doi: 10.1080/22221751.2022.2093135. Emerg Microbes Infect. 2022. PMID: 35730665 Free PMC article.
-
Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019.J Infect Dis. 2019 Oct 8;220(10):1568-1576. doi: 10.1093/infdis/jiz361. J Infect Dis. 2019. PMID: 31290537 Free PMC article.
-
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.Adv Rheumatol. 2023 Nov 28;63(1):55. doi: 10.1186/s42358-023-00339-7. Adv Rheumatol. 2023. PMID: 38017564 Clinical Trial.
-
The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.Epidemiology. 2020 Jan;31(1):43-64. doi: 10.1097/EDE.0000000000001116. Epidemiology. 2020. PMID: 31609860 Free PMC article.
References
-
- Chiu SS, Feng S, Chan KH et al. . Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. Vaccine 2016; 34:2164–9. - PubMed
-
- Chiu SS, Chan KH, Chen H et al. . Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis 2009; 49:1016–21. - PubMed
-
- Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 2002; 347:2097–103. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical